Description
Depo-Provera (medroxyprogesterone acetate) is a women's health medications agent listed in our Women's health medications directory and prescribed for pregnancy prevention (1.1) (2.1). Administered via the intramuscular route, Depo-Provera is available for delivery to U.S. residents through Canadian Pharmacy Store with a valid prescription. Review the clinical fact table, dosage directions, cautions, drug interactions, side effects, and official regulatory sources below.
Depo-Provera is a medication containing the active pharmaceutical ingredient medroxyprogesterone acetate, classified pharmacologically as a women's health medications agent (2.1). It is clinically indicated for the management of pregnancy prevention as part of a comprehensive treatment plan supervised by a licensed healthcare provider (2.1).
Within the Women's health medications section of our catalogue, patients and prescribers frequently review Depo-Provera alongside related therapies such as Provera (Medroxyprogesterone Acetate), Medroxyprogesterone Acetate, Activelle (Estradiol / Norethindrone Acetate), and Angeliq (Drospirenone, Estradiol).
Official Indications and Usage
Depo-Provera CI is indicated for use by females of reproductive potential to prevent pregnancy.
Limitations of use: The use of Depo-Provera CI is not recommended as a long-term (i.e., longer than 2 years) birth control method unless other options are considered inadequate. (1.1)
Mechanism of Action and Pharmacology
Depo-Provera CI (medroxyprogesterone acetate [mpa]) inhibits the secretion of gonadotropins which primarily prevents follicular maturation and ovulation and causes thickening of cervical mucus. These actions contribute to its contraceptive effect. (1.1)
What is Birth control?
Birth control includes methods that prevent pregnancy through different mechanisms. Suitability depends on health history, preferences, and correct use. Explore related medications below and discuss treatment options with your healthcare provider. Read our complete Birth control condition guide for appointment questions and related therapies (2.1).
Ordering Depo-Provera from Canada for U.S. Delivery
U.S. patients can order Depo-Provera (Medroxyprogesterone) in U.S. dollars with a valid prescription from a U.S.-licensed clinician. Your card is only charged after your prescription passes pharmacist safety checks and is ready to ship.
Step 1
Send Your Prescription
- Valid Rx required from a U.S.-licensed physician, NP, or PA (Rx rules).
- Upload Rx online, request a pharmacy transfer, or have your doctor fax (844) 666 – 6819.
- Order up to a 90-day personal-use supply per shipment (refill planning).
Step 2
Pharmacist Safety Check
- Multi-point dosing and interaction review completed in under 1 business day.
- Mandatory licensed pharmacist consultation via phone, voicemail, or text before dispatch.
- Verified under our Pharmacy Safety Standards.
Step 3
$14.99 USD Tracked Parcel
- Packed in discreet protective packaging for a flat $14.99 USD per order ($29.99 if combined with cold-chain).
- Tracked via Canada Post and USPS: 3 to 7 business days from Canada (7 to 14 days from international partners).
- Review full shipping and delivery details.
Step 4
U.S. Street Delivery & Payment
- Delivered to any physical U.S. street address with signature upon delivery (no P.O. Boxes).
- You see and approve the country of origin upfront before your card is charged.
- Report any delayed or damaged parcel within 48 hours for prompt resolution.
Fact Table
| Clinical Specification | Details |
|---|---|
| Brand / Product Name | Depo-Provera |
| Chemical / Generic Name | Medroxyprogesterone Acetate |
| Pharmacological Class | Women's health medications agent |
| Therapeutic Category | Women's health medications |
| Same-Ingredient Catalogue Entries | Provera (Medroxyprogesterone Acetate) |
| Protein Binding | ~86% (1.1) |
| Elimination Half-Life | ~50 days (1.1) |
| Legal Status | Rx-Only (Prescription Required) |
| Regulatory Reference Authorities | U.S. FDA (DailyMed), Health Canada (DPD), NLM MedlinePlus |
| Routes of Administration | Intramuscular |
| Dosage Forms & Strengths | Sterile Aqueous suspension: 150 mg/mL Prefilled syringes are available packaged with 22-gauge x 1 1/2 inch Terumo® SurGuard™ Needles; Vials containing |
| Primary Indications | Pregnancy Prevention |
| Pregnancy & Breastfeeding | Consult Doctor / Prescriber before use |
| FDA UNII Identifier | C2QI4IOI2G |
| NLM RxNorm Concept ID (RxCUI) | 1000126, 1000128, 1000153, 1000154 |
| FDA Application License | NDA020246 |
| Official DailyMed SetID | 199cf13e-0859-4a73-9b45-e700d0cd1049 |
| Catalogue Index Links | Letter D Index · All Medications · All Categories |
Directions
Dosage and Administration Overview
The recommended dose is 150 mg of Depo-Provera CI every 3 months (13 weeks) administered by deep, intramuscular (IM) injection in the gluteal or deltoid muscle. (1.1)
Presentations and Strengths
Sterile Aqueous suspension: 150 mg/mL Prefilled syringes are available packaged with 22-gauge x 1 1/2 inch Terumo® SurGuard™ Needles (1.1):
- Vials containing sterile aqueous suspension: 150 mg per mL.
- Prefilled syringes: prefilled syringes are available packaged with 22-gauge x 1 1/2 inch Terumo® SurGuard™ Needles.
Administration Guidance
Administer Depo-Provera by injection or infusion (Intramuscular) strictly according to your prescriber’s individualized dosing schedule (1.1). Always verify the concentration, vial or pen presentation, and dose markings prior to administration, rotate injection sites when self-injecting subcutaneously, and never share injection pens, needles, or syringes between patients.
Missed Dose Guidance
If you miss a scheduled dose of Depo-Provera, follow the missed-dose instructions in the official patient leaflet or ask your pharmacist. Do not double the next dose to make up for a missed dose (2.1).
Ingredients
Active Pharmaceutical Ingredient
The active ingredient in Depo-Provera is medroxyprogesterone acetate (2.1). Other catalogue entries containing medroxyprogesterone acetate include Provera (Medroxyprogesterone Acetate).
Excipients and Formulation Carriers
Film coatings, stabilizers, and inactive carriers vary by strength and manufacturer presentation. If you have a known allergy to lactose, dyes, sulfites, or specific preservatives, ask our pharmacist to check the exact excipient list for your selected package (2.1).
Cautions and important safety information
Boxed Warning
Warning: loss of bone mineral density (1.1):
- women who use Depo-Provera Contraceptive Injection (Depo-Provera CI) may lose significant bone mineral density. Bone loss is greater with increasing duration of use and may not be completely reversible.
- It is unknown if use of Depo-Provera CI during adolescence or early adulthood, a critical period of bone accretion, will reduce peak bone mass and increase the risk for osteoporotic fracture in later life.
- Depo-Provera CI is not recommended as a long-term (i.e., longer than 2 years) birth control method unless other options are considered inadequate..
Contraindications
The use of Depo-Provera CI is contraindicated in the following conditions (1.1):
- Active thrombophlebitis, or current or history of thromboembolic disorders, or cerebral vascular disease.
- Known or suspected malignancy of breast.
- Known hypersensitivity to Depo-Provera CI (medroxyprogesterone acetate) or any of its other ingredients.
- Significant liver disease.
- Undiagnosed vaginal bleeding.
Key Clinical Precautions
Before starting or continuing Depo-Provera, discuss your complete medical history with your healthcare provider. Key clinical cautions include (1.1):
- Hypersensitivity and anaphylaxis: Serious allergic reactions, including anaphylaxis, angioedema, and severe rash, have been reported. Discontinue use and seek immediate medical care if swelling of the face, lips, tongue, or throat or difficulty breathing occurs.
Pregnancy, Lactation, and Special Populations
There is no use for contraception in pregnancy; therefore, Depo-Provera CI should be discontinued during pregnancy. Epidemiologic studies and meta‑analyses have not found an increased risk of genital or non-genital birth defects (including cardiac anomalies and limb-reduction defects) following exposure to progestins before conception or during early pregnancy. All pregnancies have a background risk of birth defect, loss, or other adverse outcomes. In the U.S. General population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. (1.1)
Interactions
Official Drug Interaction Overview
Drugs or herbal products that induce certain enzymes, including CYP3A4, may decrease the effectiveness of contraceptive drug products. Counsel patients to use a back-up method or alternative method of contraception when enzyme inducers are used with Depo-Provera CI. (1.1)
Important Interaction Categories
Concomitant use of Depo-Provera with certain prescription medications, over-the-counter drugs, or supplements can alter how the medication works or increase the risk of side effects. Important interaction categories to review with your prescriber and pharmacist include (2.1):
- Strong CYP3A4 inhibitors and inducers (such as ketoconazole, itraconazole, clarithromycin, ritonavir, rifampin, carbamazepine, phenytoin, or St. John’s wort): Co-administration with strong CYP3A4 inhibitors can significantly increase plasma concentrations and side-effect risk, whereas CYP3A4 inducers can decrease systemic exposure and reduce efficacy.
Side effects
Like all medications, Depo-Provera can cause side effects, although not everyone experiences them. Commonly reported side effects in clinical trials and official labeling include (1.1):
- Nausea (feeling sick): Often mild to moderate and most noticeable when starting therapy or increasing the dose; eating smaller, lower-fat meals and avoiding lying down immediately after eating may help reduce nausea.
- Headache: Commonly reported during initial treatment; often improves as your body adjusts to the medication.
- Dizziness or lightheadedness: May occur especially when standing up quickly from a sitting or lying position (orthostatic changes); rise slowly and stay well hydrated.
- Drowsiness or somnolence: Use caution with driving or tasks requiring alertness until you know how this medication affects you.
- Insomnia or sleep disturbances: Taking morning doses earlier in the day (if consistent with your prescription) may reduce nighttime restlessness.
- Abdominal discomfort or stomach pain: Mild gastrointestinal upset may occur; report severe, persistent, or radiating abdominal pain promptly.
Clinical Trial and Postmarketing Adverse Reactions
The following important adverse reactions observed with the use of Depo-Provera CI are discussed in greater detail in the Warnings and Precautions section (1.1):
- Loss of Bone Mineral Density.
- Thromboembolic disease.
- Breast Cancer.
- Anaphylaxis and Anaphylactoid Reactions.
- Bleeding Irregularities.
- Weight Gain Most common adverse reactions (incidence >5%): menstrual irregularities (bleeding or spotting) 57% at 12 months, 32% at 24 months, abdominal pain/discomfort 11%, weight gain >10 lb at 24 months 38%, dizziness 6%, headache 17%, nervousness 11%, decreased libido 6%.
When to Seek Immediate Medical Attention
Contact your physician or seek urgent medical care if you experience signs of a severe allergic reaction (hives, difficulty breathing, or swelling of the face, lips, tongue, or throat), severe dizziness or fainting, unexplained severe pain, or any sudden change in your clinical symptoms (2.1).
Storage and handling
What is a generic drug?
A generic medication contains the exact same active pharmaceutical ingredient (medroxyprogesterone acetate) as its brand-name counterpart and is formulated to deliver the same dosage strength, route of administration, safety profile, quality, and therapeutic performance (2.1). Regulatory authorities require generic manufacturers to demonstrate bioequivalence, meaning the generic medication releases its active ingredient into the bloodstream at virtually the same rate and to the same extent as the innovator brand.
While a generic tablet, capsule, or inhaler may differ in color, shape, scoring, or packaging due to trademark laws that govern brand appearance, its clinical mechanism and active ingredient match the reference medicine. Because generic manufacturers do not repeat the initial discovery and multi-phase clinical trial investments of the original brand, generic equivalents offer substantial cost savings for patients paying out of pocket.
Canadian Pharmacy Store delivers prescription and over-the-counter medications to U.S. residents. Browse our Women's health medications directory, explore all medications A-Z, review how ordering works and prescription requirements, or call 1-888-868-1920 for personal assistance matching your prescription.
Related Medications in Our Catalogue
- Provera (Medroxyprogesterone Acetate), listed in Women's health medications
- Medroxyprogesterone Acetate, listed in Women's health medications
- Activelle (Estradiol / Norethindrone Acetate), listed in Women's health medications
- Angeliq (Drospirenone, Estradiol), listed in Women's health medications
- Antagon (Ganirelix Acetate), listed in Women's health medications
- Aranelle (Norethindrone Acetate / Ethinyl Estradiol), listed in Women's health medications
Related Categories, Directories, and Ordering Guides
- Women's health medications Category Directory
- Medications Starting with D
- Active Ingredient Directory
- What to prepare before a prescription order
- How to compare prescription prices without mixing up the product
- How to Order Prescription Medication
- Prescription Requirements
- Ordering Medication from Canada Guide
- Caregiver Ordering Guide
- Explore Medications
- Explore Categories
Frequently Asked Questions About Depo-Provera
What is Depo-Provera and what active ingredient does it contain?
Depo-Provera is a women's health medications agent containing the active pharmaceutical ingredient medroxyprogesterone acetate. It is supplied for intramuscular administration and requires a valid prescription where applicable.
How does Depo-Provera work in the body?
Depo-Provera CI (medroxyprogesterone acetate [mpa]) inhibits the secretion of gonadotropins which primarily prevents follicular maturation and ovulation and causes thickening of cervical mucus. These actions contribute to its contraceptive effect.
What conditions is Depo-Provera prescribed to treat?
Depo-Provera is primarily indicated for pregnancy prevention. Your prescribing clinician determines the appropriate indication, strength, and treatment duration based on your individual diagnosis and medical history.
How should I take or use Depo-Provera?
Follow the exact dosage, frequency, and administration instructions printed on your prescription label. Depo-Provera is administered via the intramuscular route. Administer it consistently at the same time(s) as directed, and never adjust your dose or stop therapy without speaking with your prescriber.
What are the most common side effects of Depo-Provera?
Commonly reported side effects of Depo-Provera include feeling sick, headache, dizziness, sleepiness, difficulty sleeping, and abdominal pain. Most mild side effects improve as your body adjusts to treatment, but you should notify your doctor or pharmacist if symptoms persist or worsen.
What medications or substances can interact with Depo-Provera?
Important interaction categories for Depo-Provera include medicines that strongly affect CYP3A enzymes. Always share a complete list of your prescription drugs, over-the-counter medicines, vitamins, and herbal supplements with your pharmacist before starting treatment.
Can Depo-Provera be used during pregnancy or breastfeeding?
If you are pregnant, planning to become pregnant, or breastfeeding, consult your prescribing physician before using Depo-Provera to weigh the clinical benefits and potential risks.
Do I need a prescription to buy Depo-Provera online from Canada?
Yes. A valid prescription written by a U.S.-licensed physician, nurse practitioner, or physician assistant is required to buy Depo-Provera (Medroxyprogesterone) through our licensed Canadian pharmacy partners. Valid prescriptions go through multiple safety checks in less than 1 business day, followed by a mandatory request to speak with a licensed pharmacist for a consultation (watch your phone, voicemails, and text messages).
Does Depo-Provera have a generic equivalent (Medroxyprogesterone) at a Canada pharmacy?
Yes. A lower-cost generic equivalent (Medroxyprogesterone Acetate) containing Medroxyprogesterone is available alongside brand-name Depo-Provera in our Canada pharmacy catalogue.
Other Brands: ProveraGeneric: Medroxyprogesterone Acetate
How is Depo-Provera shipped to U.S. residents, and how much does shipping cost?
Depo-Provera ships in discreet protective packaging at a flat rate of $14.99 USD per order via Canada Post and USPS with full tracking (if combined in the same order with a cold-chain item, total shipping is $29.99 USD in a larger container). Once your valid prescription passes safety checks (<1 business day) and you respond to the mandatory licensed pharmacist consultation request via phone, voicemail, or text message, delivery takes 3 to 7 business days from Manitoba, Canada (or 7 to 14 business days from licensed partner pharmacies in the UK, Singapore, and Mauritius). You see and choose the country of origin before you pay, and your Visa, Mastercard, or Discover card is only charged when your order is ready to ship.
How can I send or transfer my Depo-Provera prescription, or ask about an unlisted strength?
You can upload a clear photo or PDF of your Depo-Provera prescription online, request a prescription transfer or direct prescriber coordination from our team, or have your prescriber fax the prescription directly to (844) 666 – 6819. You may order up to a 90-day personal-use supply per shipment. If you do not see your exact prescribed strength or manufacturer listed, call 1-888-868-1920 and our staff will check availability across our licensed pharmacy partners.
References & Official Sources
Clinical, pharmacological, and safety facts for Depo-Provera (Medroxyprogesterone) are compiled directly from official regulatory prescribing labels and primary biomedical databases:
- (1.1) Depo-Provera. U.S. National Library of Medicine / U.S. Food and Drug Administration (DailyMed). Official U.S. FDA / DailyMed Structured Product Labeling (SPL). (Accessed 2026-10-29).
- (2.1) MedlinePlus Medical Encyclopedia: Birth Control. MedlinePlus / National Library of Medicine. U.S. National Library of Medicine, MedlinePlus Drug & Health Information. (Accessed 2026-10-29).
- (3.1) Health Canada Drug Product Database (DPD), Authorized Product Records. Health Canada / Government of Canada. Health Canada Drug Product Database & Official Product Monograph. (Accessed 2026-10-29).
